intelligence united
Foundation on years of scientific excellence, building on novel insight vision.
Mikko Turunen
Mikko Turunen, PhD, Docent of Molecular Medicine at the University of Eastern Finland, has +25 years of experience in the development of gene therapies. Throughout his career, his research focus has been non-coding RNAs, cardiovascular disease, and gene delivery to animals. He was the first to show transcriptional gene activation by small RNAs in vivo (2009). Turunen has 67 scientific articles, over 3100 citations,
and H-index of 26.
Linkedin: https://www.linkedin.com/in/mikko-turunen-8399293/
Email: mikko.turunen@rnatives.com
Juhani Lahdenperä
Founding CEO, Juhani Lahdenperä, M.Sc., is a seasoned CEO with over 15 years of experience in the biotechnology business management and leadership – he was previously eight years as a start-up CEO in PlexPress and Hermo Pharma, and afterward, he has been helping early-stage programs in their commercialization via Biotech Start-Up Management. He has received five innovation awards personally or the companies he´s represented in the past. During the early academic career, he published in Nature amongst other peer-reviewed journals. His key reference is former Roche executive Professor Jonathan Knowles.
Linkedin: https://www.linkedin.com/in/juhani-lahdenper%C3%A4/
Tiia Turunen
Tiia Turunen, PhD, is Laboratory Manager and co-founder of RNatives. She has +14 years of experience in the research and development of Epigenetherapy. She obtained her PhD in 2016 from University of Eastern Finland and completed her post-doctoral training 2017-2018 in Samir EL Andaloussi’s laboratory in Karolinska Institutet, Sweden. She has strong expertise in non-coding RNAs, epigenetics, extracellular vesicles and laboratory leadership.
Linkedin: https://www.linkedin.com/in/tiia-turunen-7299bb17/
Email: tiia.turunen@rnatives.com
Pia Laitinen
Pia Laitinen, MSc, is the head of manufacturing and she has +7 years of experience in the drug development of small RNAs, including formulation and up- and downstream manufacturing.
Research and development team
Our dedicated team of three scientists with average of five years of post-graduate training have special skills in the areas of molecular biology, bioinformatics, cellular biology and up- and downstream manufacturing of RNA-medicines.